DK160556C - Benzodioxinpyrrolderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse - Google Patents

Benzodioxinpyrrolderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse

Info

Publication number
DK160556C
DK160556C DK184085A DK184085A DK160556C DK 160556 C DK160556 C DK 160556C DK 184085 A DK184085 A DK 184085A DK 184085 A DK184085 A DK 184085A DK 160556 C DK160556 C DK 160556C
Authority
DK
Denmark
Prior art keywords
sup
pyrol
benzodioxin
procedures
preparing
Prior art date
Application number
DK184085A
Other languages
English (en)
Other versions
DK184085A (da
DK160556B (da
DK184085D0 (da
Inventor
John Kitchin
Peter Clive Cherry
Adrian John Pipe
Andrew James Crame
Alan David Borthwick
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848410456A external-priority patent/GB8410456D0/en
Priority claimed from GB858503975A external-priority patent/GB8503975D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DK184085D0 publication Critical patent/DK184085D0/da
Publication of DK184085A publication Critical patent/DK184085A/da
Publication of DK160556B publication Critical patent/DK160556B/da
Application granted granted Critical
Publication of DK160556C publication Critical patent/DK160556C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Light Receiving Elements (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Medicinal Preparation (AREA)
DK184085A 1984-04-24 1985-04-24 Benzodioxinpyrrolderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse DK160556C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8410456 1984-04-24
GB848410456A GB8410456D0 (en) 1984-04-24 1984-04-24 Chemical compounds
GB858503975A GB8503975D0 (en) 1985-02-15 1985-02-15 Chemical compounds
GB8503975 1985-02-15

Publications (4)

Publication Number Publication Date
DK184085D0 DK184085D0 (da) 1985-04-24
DK184085A DK184085A (da) 1985-10-25
DK160556B DK160556B (da) 1991-03-25
DK160556C true DK160556C (da) 1991-09-02

Family

ID=26287645

Family Applications (2)

Application Number Title Priority Date Filing Date
DK184085A DK160556C (da) 1984-04-24 1985-04-24 Benzodioxinpyrrolderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK141590A DK160824C (da) 1984-04-24 1990-06-08 Benzodioxanderivater

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK141590A DK160824C (da) 1984-04-24 1990-06-08 Benzodioxanderivater

Country Status (21)

Country Link
US (1) US4880801A (da)
EP (2) EP0162593B1 (da)
JP (2) JPH02270819A (da)
KR (1) KR920003065B1 (da)
AT (1) ATE55605T1 (da)
AU (1) AU577367B2 (da)
CA (1) CA1256111A (da)
CS (1) CS402491A3 (da)
CY (2) CY1532A (da)
DE (2) DE3579189D1 (da)
DK (2) DK160556C (da)
ES (2) ES8607311A1 (da)
FI (1) FI84069C (da)
GB (3) GB2201414B (da)
GR (1) GR850993B (da)
HK (2) HK42890A (da)
IL (1) IL75011A (da)
MX (1) MX9203233A (da)
NZ (1) NZ211885A (da)
PT (1) PT80344B (da)
SG (2) SG23590G (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8526210D0 (en) * 1985-10-23 1985-11-27 Glaxo Group Ltd Chemical compounds
GB8526209D0 (en) * 1985-10-23 1985-11-27 Glaxo Group Ltd Chemical process
US5225431A (en) * 1987-10-23 1993-07-06 Burroughs Wellcome Co. Therapeutic substituted indole compounds and compositions thereof
GB8828032D0 (en) * 1988-12-01 1989-01-05 Glaxo Group Ltd Medicaments
GB9012469D0 (en) * 1990-06-05 1990-07-25 Glaxo Group Ltd Medicaments
GB9119466D0 (en) * 1991-09-12 1991-10-23 Glaxo Group Ltd Chemical compounds
US6451806B2 (en) 1999-09-29 2002-09-17 Adolor Corporation Methods and compositions involving opioids and antagonists thereof
US6469030B2 (en) 1999-11-29 2002-10-22 Adolor Corporation Methods for the treatment and prevention of ileus
CA2522666A1 (en) * 2003-04-18 2004-10-28 Pharmacia & Upjohn Company Llc Combination therapies for chronic obstructive pulmonary disease (copd)
GB2503187A (en) * 2011-09-15 2013-12-25 Univ Sussex Composition for use in the treatment of neurodevelopmental disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2485539A1 (fr) * 1980-06-26 1981-12-31 Sori Soc Rech Ind Nouveau derive de pyranno-indole, son procede de preparation et son application en therapeutique
IL70034A0 (en) * 1982-10-25 1984-01-31 Glaxo Group Ltd Heterocyclic amino compounds,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
GB2201414B (en) 1988-12-29
ES542516A0 (es) 1986-06-16
AU577367B2 (en) 1988-09-22
ES8607311A1 (es) 1986-06-16
ES551509A0 (es) 1988-02-01
CA1256111A (en) 1989-06-20
SG23590G (en) 1990-07-13
GR850993B (da) 1985-11-25
MX9203233A (es) 1992-07-01
US4880801A (en) 1989-11-14
HK112093A (en) 1993-10-29
EP0359290A1 (en) 1990-03-21
PT80344A (en) 1985-05-01
FI84069C (fi) 1991-10-10
ES8801545A1 (es) 1988-02-01
HK42890A (en) 1990-06-08
DK184085A (da) 1985-10-25
DK160824B (da) 1991-04-22
DE3587511D1 (de) 1993-09-09
GB2157691A (en) 1985-10-30
EP0359290B1 (en) 1993-08-04
FI851611L (fi) 1985-10-25
JPH02270819A (ja) 1990-11-05
CY1695A (en) 1994-01-14
DK141590A (da) 1990-06-08
DK141590D0 (da) 1990-06-08
NZ211885A (en) 1988-09-29
GB2157691B (en) 1989-07-05
DK160556B (da) 1991-03-25
GB8510449D0 (en) 1985-05-30
DK160824C (da) 1991-10-07
EP0162593A1 (en) 1985-11-27
KR920003065B1 (ko) 1992-04-13
GB8802949D0 (en) 1988-03-09
KR850007259A (ko) 1985-12-02
SG12293G (en) 1993-04-16
CY1532A (en) 1990-11-16
DE3579189D1 (de) 1990-09-20
FI851611A0 (fi) 1985-04-24
IL75011A (en) 1990-02-09
EP0162593B1 (en) 1990-08-16
FI84069B (fi) 1991-06-28
PT80344B (pt) 1987-09-30
GB8728949D0 (en) 1988-01-27
AU4166785A (en) 1985-10-31
DE3587511T2 (de) 1993-11-18
GB2201414A (en) 1988-09-01
ATE55605T1 (de) 1990-09-15
DK184085D0 (da) 1985-04-24
CS402491A3 (en) 1992-10-14
JPH02270878A (ja) 1990-11-05

Similar Documents

Publication Publication Date Title
IL99571A (en) Process for the preparation of water soluble 10-hydroxy-9-(substituted methyl)camptothecin analogs
DK160556C (da) Benzodioxinpyrrolderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
FI922806A0 (fi) Substituerade 4-fenyl-4 -piperidinkarboxamider med baode lokalbedoevande och smaertstillande effekt samt foerfaranden foer deras framstaellning.
ATE8144T1 (de) Indolobenzoxazine, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen.
DK397383A (da) 2-nitro-1,1-ethendiaminer, fremgangsmaader til fremstilling deraf samt deres anvendelse som laegemidler
ES521440A0 (es) Un procedimiento para preparar derivados de imidazolina.
ATE20062T1 (de) Benzamide, ihre salze, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DE3661829D1 (en) 0-substituted 3-oxy-pyridinium salts, process for their preparation and their use as fungicides in crop protection
ATE53388T1 (de) 3,5-dialkyl-4,6-diaryl-tetrahydro-2h-1,3,5thiadiazin-2-thion-derivate, verfahren zu ihrer herstellung und sie enthaltende antihyperlipidemische mittel.
ES550817A0 (es) Procedimiento para preparar derivados de n-carboxialquil-2--oxo-3-diaril-5,6-triazinas
NO851206L (no) Fremgangsmaate for fremstilling av terapeutisk virksomme 1,4-dihydropyridiner
JPS5344575A (en) Preparation of hydantoin derivatives

Legal Events

Date Code Title Description
PBP Patent lapsed